This prospective, multi-center, real-world study is conducted to investigate the impact of different treatment strategies (systemic chemotherapy combined with oophorectomy or with other local treatment or chemotherapy alone) on the prognosis of ovarian metastatic colorectal cancer patients.
This study prospectively collects data of patients diagnosed with ovarian metastatic colorectal cancer, meeting inclusion criteria and signing the informed consent. Patients' treatment strategies and survival outcome in the real world will be faithfully recorded.
Study Type
OBSERVATIONAL
Enrollment
400
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
RECRUITINGCancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, China
RECRUITINGWest China Hospital of Sichuan University
Chengdu, Sichuan, China
Ovarian specific overall survival
Calculated from the date of diagnosis with ovarian metastasis to death (caused by cancer) or last follow-up time.
Time frame: up to 3 years
Ovarian specific objective response rate
Response rate of ovarian metastases to systemic chemotherapy
Time frame: 6 months
Extra-ovarian specific objective response rate
Response rate of extra-ovarian metastases to systemic chemotherapy
Time frame: 6 months
Progression free survival
Survival time from treatment start to disease progression or death.
Time frame: 6 months
Quality of life questionnaire
Quality of life during treatment
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Changhai Hospital, Naval Medical University
Shanghai, China
RECRUITING